
Chintan Nareshchandra Sheth
About Chintan Nareshchandra Sheth
Data last updated:
Chintan Nareshchandra Sheth is a Director at Skycraper Clinical Research Solutions Private Limited (since 2017) and Director at Tripadaclinical Solutions Private Limited (since 2023). The companies operate in Research & Development and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹88.5 Lakh; the largest is Skycraper Clinical Research Solutions Private Limited at ₹87 Lakh (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 24 Mar 2017 | 2017 | ₹87 Lakh (FY 2024) | Active | |
| Director | 02 May 2023 | 2023 | ₹1.6 Lakh (FY 2025) | Active |
Board colleagues of Chintan Nareshchandra Sheth
| Name | DIN | Company | Designation |
|---|---|---|---|
| Naynaben Ashvinbhai Vyas | 08569488 | Skycraper Clinical Research Solutions Private Limited , Tripadaclinical Solutions Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Chintan Nareshchandra Sheth
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Chintan Nareshchandra Sheth
Chintan Nareshchandra Sheth currently holds 2 directorships: Skycraper Clinical Research Solutions Private Limited (Director, since 24 Mar 2017, revenue ₹87 Lakh (FY 2024)); Tripadaclinical Solutions Private Limited (Director, since 02 May 2023, revenue ₹1.6 Lakh (FY 2025)).
Chintan Nareshchandra Sheth was first appointed on 24 Mar 2017 as Director at Skycraper Clinical Research Solutions Private Limited. The most recent appointment on record is 02 May 2023 at Tripadaclinical Solutions Private Limited.
The 2 current companies of Chintan Nareshchandra Sheth that report revenue have a combined latest revenue of ₹88.5 Lakh: Skycraper Clinical Research Solutions Private Limited ₹87 Lakh (FY 2024); Tripadaclinical Solutions Private Limited ₹1.6 Lakh (FY 2025).
The current boards of Chintan Nareshchandra Sheth's companies include Naynaben Ashvinbhai Vyas (Skycraper Clinical Research Solutions Private Limited).